Invention Grant
- Patent Title: Inhaled combination therapy
- Patent Title (中): 吸入联合治疗
-
Application No.: US13829846Application Date: 2013-03-14
-
Publication No.: US09084799B2Publication Date: 2015-07-21
- Inventor: Justian Craig Fox , Mary Frances Fitzgerald , Harry Finch
- Applicant: Pulmagen Therapeutics (Synergy) Limited
- Applicant Address: GB Buckinghamshire
- Assignee: Pulmagen Therapeutics (Synergy) Limited
- Current Assignee: Pulmagen Therapeutics (Synergy) Limited
- Current Assignee Address: GB Buckinghamshire
- Agency: Morgan, Lewis & Bockius LLP
- Priority: GB0502949.1 20050211; GB0526124.3 20051222
- Main IPC: A01N45/00
- IPC: A01N45/00 ; A61K31/56 ; A61K31/58 ; A61K31/522 ; A61K31/573
Abstract:
There is provided the use of a methylxanthine derivative such as theophylline and a steroid in a synergistic combination for the treatment of chronic obstructive pulmonary disease, wherein the combination is administered by the inhaled route for pulmonary delivery.
Public/Granted literature
- US20130203716A1 Inhaled Combination Therapy Public/Granted day:2013-08-08
Information query
